How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review

• Published in: Malaria Journal
• Main Authors: Sophie Moss, Emilia Mańko, Sanjeev Krishna, Susana Campino, Taane G. Clark, Anna Last
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMC 2022
• Subjects: Antimalarial resistance; Dihydroartemisinin-piperaquine; Mass drug administration; Molecular markers; Arctic medicine. Tropical medicine; RC955-962; Infectious and parasitic diseases; RC109-216; Arctic; Prisma
• Online Access: https://doi.org/10.1186/s12936-022-04181-y; https://doaj.org/article/8e19bde5456f4e78ae18d04d7fca81e1

Abstract The World Health Organization (WHO) recommends surveillance of molecular markers of resistance to anti-malarial drugs. This is particularly important in the case of mass drug administration (MDA), which is endorsed by the WHO in some settings to combat malaria. Dihydroartemisinin-piperaquin...